CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $86.20 billion. The enterprise value is $87.75 billion.
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025, before market open.
Earnings Date | Feb 12, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
CME Group has 360.36 million shares outstanding. The number of shares has increased by 0.13% in one year.
Current Share Class | 360.36M |
Shares Outstanding | 360.36M |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 0.32% |
Owned by Institutions (%) | 89.73% |
Float | 358.85M |
Valuation Ratios
The trailing PE ratio is 25.16 and the forward PE ratio is 23.28. CME Group's PEG ratio is 4.81.
PE Ratio | 25.16 |
Forward PE | 23.28 |
PS Ratio | 14.26 |
Forward PS | 13.77 |
PB Ratio | 3.05 |
P/TBV Ratio | n/a |
P/FCF Ratio | 23.80 |
P/OCF Ratio | 23.23 |
PEG Ratio | 4.81 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 20.84, with an EV/FCF ratio of 24.19.
EV / Earnings | 25.64 |
EV / Sales | 14.54 |
EV / EBITDA | 20.84 |
EV / EBIT | 22.67 |
EV / FCF | 24.19 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.
Current Ratio | 1.02 |
Quick Ratio | 0.03 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.90 |
Debt / FCF | 1.06 |
Interest Coverage | 24.20 |
Financial Efficiency
Return on equity (ROE) is 12.30% and return on invested capital (ROIC) is 7.55%.
Return on Equity (ROE) | 12.30% |
Return on Assets (ROA) | 1.84% |
Return on Capital (ROIC) | 7.55% |
Revenue Per Employee | $1.69M |
Profits Per Employee | $959,916 |
Employee Count | 3,565 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $985.00 million in taxes.
Income Tax | 985.00M |
Effective Tax Rate | 22.13% |
Stock Price Statistics
The stock price has increased by +11.59% in the last 52 weeks. The beta is 0.57, so CME Group's price volatility has been lower than the market average.
Beta (5Y) | 0.57 |
52-Week Price Change | +11.59% |
50-Day Moving Average | 231.31 |
200-Day Moving Average | 214.37 |
Relative Strength Index (RSI) | 57.98 |
Average Volume (20 Days) | 2,382,533 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CME Group had revenue of $6.03 billion and earned $3.42 billion in profits. Earnings per share was $9.51.
Revenue | 6.03B |
Gross Profit | 6.03B |
Operating Income | 3.87B |
Pretax Income | 4.25B |
Net Income | 3.42B |
EBITDA | 4.21B |
EBIT | 3.87B |
Earnings Per Share (EPS) | $9.51 |
Full Income Statement Balance Sheet
The company has $2.43 billion in cash and $3.84 billion in debt, giving a net cash position of -$1.41 billion or -$3.91 per share.
Cash & Cash Equivalents | 2.43B |
Total Debt | 3.84B |
Net Cash | -1.41B |
Net Cash Per Share | -$3.91 |
Equity (Book Value) | 28.22B |
Book Value Per Share | 78.47 |
Working Capital | 2.32B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $3.72 billion and capital expenditures -$88.60 million, giving a free cash flow of $3.63 billion.
Operating Cash Flow | 3.72B |
Capital Expenditures | -88.60M |
Free Cash Flow | 3.63B |
FCF Per Share | $10.07 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of 64.14% and 57.43%.
Gross Margin | 100.00% |
Operating Margin | 64.14% |
Pretax Margin | 73.76% |
Profit Margin | 57.43% |
EBITDA Margin | 69.77% |
EBIT Margin | 64.14% |
FCF Margin | 60.13% |
Dividends & Yields
This stock pays an annual dividend of $10.40, which amounts to a dividend yield of 4.35%.
Dividend Per Share | $10.40 |
Dividend Yield | 4.35% |
Dividend Growth (YoY) | 7.77% |
Years of Dividend Growth | 13 |
Payout Ratio | 109.36% |
Buyback Yield | -0.13% |
Shareholder Yield | 4.21% |
Earnings Yield | 3.96% |
FCF Yield | 4.20% |
Dividend Details Analyst Forecast
The average price target for CME Group is $229.69, which is -3.98% lower than the current price. The consensus rating is "Hold".
Price Target | $229.69 |
Price Target Difference | -3.98% |
Analyst Consensus | Hold |
Analyst Count | 16 |
Revenue Growth Forecast (5Y) | 4.85% |
EPS Growth Forecast (5Y) | 6.38% |
Stock Forecasts Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
Last Split Date | Jul 23, 2012 |
Split Type | Forward |
Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.63 |
Piotroski F-Score | 6 |